examples of glp-1 drugs medication and its types What to know about the
Description
The total effect is nevertheless meaningful (OR = 0.59,95% CI: 0.390.89, P = 0.0109), indicating that there is a significant causal association between GLP-1RA and DR risk reduction in the European population
India is projected to show the highest regional CAGR at 8.4% during the forecast period, driven by the growing prevalence of diabetes, increasing healthcare access, and expanding awareness about GLP-1 therapies in the region
Additionally, patients receiving GLP-1 medications often have metabolic conditions that independently affect cancer risk, making it challenging to isolate drug effects
Hydroxyurea, a cornerstone of sickle cell treatment, is considered a teratogen, so it comes off the table
